DOI QR코드

DOI QR Code

Influence of Intravenous Contrast Medium on Dose Calculation Using CT in Treatment Planning for Oesophageal Cancer

  • Li, Hong-Sheng (Department of Radiation Oncology, Cancer Hospital and Institute, Tianjin Medical University) ;
  • Chen, Jin-Hu (Department of Radiation Physics, Key Laboratory of Radiation Oncology of Shandong Province, Shandong Cancer Hospital and Institute) ;
  • Zhang, Wei (Department of Radiation Oncology, Cancer Hospital and Institute, Tianjin Medical University) ;
  • Shang, Dong-Ping (Department of Radiation Physics, Key Laboratory of Radiation Oncology of Shandong Province, Shandong Cancer Hospital and Institute) ;
  • Li, Bao-Sheng (Department of Radiation Oncology (Chest Section), Shandong Cancer Hospital and Institute) ;
  • Sun, Tao (Department of Radiation Physics, Key Laboratory of Radiation Oncology of Shandong Province, Shandong Cancer Hospital and Institute) ;
  • Lin, Xiu-Tong (Department of Radiation Physics, Key Laboratory of Radiation Oncology of Shandong Province, Shandong Cancer Hospital and Institute) ;
  • Yin, Yong (Department of Radiation Physics, Key Laboratory of Radiation Oncology of Shandong Province, Shandong Cancer Hospital and Institute)
  • Published : 2013.03.30

Abstract

Objective: To evaluate the effect of intravenous contrast on dose calculation in radiation treatment planning for oesophageal cancer. Methods: A total of 22 intravein-contrasted patients with oesophageal cancer were included. The Hounsfield unit (HU) value of the enhanced blood stream in thoracic great vessels and heart was overridden with 45 HU to simulate the non-contrast CT image, and 145 HU, 245 HU, 345 HU, and 445 HU to model the different contrast-enhanced scenarios. 1000 HU and -1000 HU were used to evaluate two non-physiologic extreme scenarios. Variation in dose distribution of the different scenarios was calculated to quantify the effect of contrast enhancement. Results: In the contrast-enhanced scenarios, the mean variation in dose for planning target volume (PTV) was less than 1.0%, and those for the total lung and spinal cord were less than 0.5%. When the HU value of the blood stream exceeded 245 the average variation exceeded 1.0% for the heart V40. In the non-physiologic extreme scenarios, the dose variation of PTV was less than 1.0%, while the dose calculations of the organs at risk were greater than 2.0%. Conclusions: The use of contrast agent does not significantly influence dose calculation of PTV, lung and spinal cord. However, it does have influence on dose accuracy for heart.

References

  1. Choi Y, Kim JK, Lee HS, et al (2006). Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer. Radiother Oncol, 81, 158-62. https://doi.org/10.1016/j.radonc.2006.09.010
  2. Eslick GD (2009). Epidemiology of esophageal cancer. Gastroenterol Clin North Am, 38, 17-25. https://doi.org/10.1016/j.gtc.2009.01.008
  3. Kamangar F, Dores GM, Anderson WF (2006). Patterns of cancer incidence, mortality, and prevalence across five continents, defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 24, 2137-50. https://doi.org/10.1200/JCO.2005.05.2308
  4. Lees J, Holloway L, Fuller M, Forstner D (2005). Effect of intravenous contrast on treatment planning system dose calculations in the lung. Australas Phys Eng Sci Med, 28, 190-5. https://doi.org/10.1007/BF03178715
  5. Letourneau D, Finlay M, O'Sullivan B, et al (2008). Lack of influence of intravenous contrast on head and neck IMRT dose distributions. Acta Oncol, 47, 90-4. https://doi.org/10.1080/02841860701418861
  6. Liauw SL, Amdur RJ, Mendenhall WM, Palta J, Kim S (2005). The effect of intravenous contrast on intensity-modulated radiation therapy dose calculations for head and neck cancer. Am J Clin Oncol, 28, 456-9. https://doi.org/10.1097/01.coc.0000170796.89560.02
  7. Ramm U, Damrau M, Mose S, et al (2001). Influence of CT contrast agents on dose calculations in a 3D treatment planning system. Phys Med Biol, 46, 2631-5. https://doi.org/10.1088/0031-9155/46/10/308
  8. Shibamoto Y, Naruse A, Fukuma H, Ayakawa S, Sugie C, Tomita N (2007). Influence of contrast materials on dose calculation in radiotherapy planning using computed tomography for tumors at various anatomical regions, a prospective study. Radiother Oncol, 84, 52-5. https://doi.org/10.1016/j.radonc.2007.05.015
  9. Shi W, Liu C, Lu B, et al (2010). The effect of intravenous contrast on photon radiation therapy dose calculations for lung cancer. Am J Clin Oncol, 33, 153-6.
  10. Weber DC, Rouzaud M, Miralbell R (2001). Bladder opacification does not significantly influence dose distribution in conformal radiotherapy of prostate cancer. Radiother Oncol, 59, 95-7. https://doi.org/10.1016/S0167-8140(01)00306-1

Cited by

  1. Effect of CT Contrast Media on Radiation Therapy Planning (Head & Neck Cancer and Prostate Cancer) vol.26, pp.5, 2016, https://doi.org/10.4283/JKMS.2016.26.5.173